Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

NCT01603069 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients

NCT00537485 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)

NCT01515774 ·Status: UNKNOWN ·Phase: PHASE4

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01491529 ·Status: COMPLETED ·Phase: PHASE2

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

NCT04658186 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia

NCT05297201 ·Status: COMPLETED ·Phase: PHASE2

A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients

NCT01628848 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease

NCT06175767 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD)

NCT04875962 ·Status: COMPLETED ·Phase: PHASE1

A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients

NCT01634243 ·Status: COMPLETED ·Phase: PHASE2

A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants

NCT02337764 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients

NCT01628965 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Impact of Pharmaceutical Care on Drug-related Problems in Patients With Parkinson's Disease

NCT05410210 ·Status: COMPLETED ·Phase: NA

Is Long-term Use of Amantadine Effective in PD?

NCT04260581 ·Status: UNKNOWN ·Phase: NA

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

NCT01929317 ·Status: TERMINATED ·Phase: PHASE3

A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

NCT02337751 ·Status: COMPLETED ·Phase: PHASE3

PF-06669571 In Subjects With Idiopathic Parkinson's Disease

NCT02565628 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

NCT00203164 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor

NCT02668146 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline

NCT01879748 ·Status: COMPLETED ·Phase: PHASE1

A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients

NCT01628926 ·Status: COMPLETED ·Phase: PHASE3

Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life

NCT01100073 ·Status: COMPLETED

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

NCT00148486 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01385592 ·Status: COMPLETED ·Phase: PHASE2

A Study of KW-6356 in Subjects With Early Parkinson's Disease

NCT02939391 ·Status: COMPLETED ·Phase: PHASE2